Physical activity and type 2 diabetes. Recommandations of the SFD (Francophone Diabetes Society) diabetes and physical activity working group

Diabetes and Metabolism

Volumn 39, Issue 3, 2013, Pages 205-216

  Duclos, M ^a,b   Oppert, J M ^c   Verges, B ^d   Coliche, V ^e   Gautier, J F ^f   Guezennec, Y ^g   Reach, G ^h   Strauch, G ⁱ  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b INRA and University of Auvergne   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Clinique SSR les Rosiers   (France)

^e Centre Hospitalier Duchenne   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g Centre national du Rugby   (France)

^h AVICENNE HOSPITAL   (France)

ⁱ Union sports et diabète ^*  (France)

Author keywords

Evidence based medicine; Physical activity; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BEHAVIOR CHANGE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CLIMATE; COMORBIDITY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIETARY INTAKE; DISEASE SEVERITY; ENDURANCE; ENDURANCE TRAINING; ENERGY EXPENDITURE; EXERCISE; FAMILY HISTORY; FOLLOW UP; FOOT MALFORMATION; FUNCTIONAL STATUS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART REHABILITATION; HUMAN; HYPOGLYCEMIA; IMMOBILIZATION; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN SENSITIVITY; KIDNEY DISEASE; LIFESTYLE MODIFICATION; LIPID METABOLISM; MEDICAL SOCIETY; META ANALYSIS (TOPIC); MICROALBUMINURIA; MUSCLE CONTRACTION; MUSCLE EXERCISE; MUSCLE TRAINING; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN CONSUMPTION; PATIENT MONITORING; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; PRESCRIPTION; PROLIFERATIVE RETINOPATHY; QUALITY OF LIFE; REHABILITATION; RESISTANCE TRAINING; RESTING HEART RATE; RETINA DETACHMENT; SEDENTARY LIFESTYLE; SELF MONITORING; SENSORIMOTOR NEUROPATHY; SITTING; SOCIAL SUPPORT; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE ACTIVATION; WAIST CIRCUMFERENCE;

DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; EXERCISE; FRANCE; HUMANS; MOTOR ACTIVITY;

EID: 84878658472     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.03.005     Document Type: Article

References (52)

1. Gautier J.F., Berne C., Grimm J.J., Lobel B., Coliche V., Mollet E. Physical activity and diabetes. Diabetes Metab 1998, 24:281-290.
2. Physical Activity Contexts and effects on health. Synthesis and recommendations. Collection Expertise collective 2008, Editions INSERM, Paris.
3. Oppert J.M. Sédentarité, inactivité physique et obésité. Traité de Médecine et de chirurgie de l'obésité 2011, Lavoisier Médecine Sciences ed. A. Basdevant, J.L. Bouillot, K. Clement, J.M. Oppert, P. Tounian (Eds.).
4. Pate R.R., O'Neill J.R., Lobelo F. The evolving definition of "sedentary". Exerc Sport Sci Rev 2008, 36:173-178.
5. Gulve E.A. Exercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy. Phys Ther 2008, 88:1297-1321.
6. Kennedy J.W., Hirshman M.F., Gervino E.V., Ocel J.V., Forse R.A., Hoenig S.J., et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999, 48:1192-1197.
7. Perseghin G., Price T.B., Petersen K.F., Roden M., Cline G.W., Gerow K., et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996, 335:1357-1362.
8. Praet S.F., van Loon L.J. Optimizing the therapeutic benefits of exercise in Type 2 diabetes. J Appl Physiol 2007, 103:1113-1120.
9. Perez-Martin A., Dumortier M., Raynaud E., Brun J.F., Fedou C., Bringer J., et al. Balance of substrate oxidation during submaximal exercise in lean and obese people. Diabetes Metab 2001, 27:466-474.
10. Wilmore J.H., Costill D.L. Physiologie du sport et de l'exercice 2002, De Boeck Université ed, Bruxelles.
11. Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537-544.
12. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
13. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
14. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A.D., Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006, 49:289-297.
15. Kosaka K., Noda M., Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 2005, 67:152-162.
16. Laaksonen D.E., Lindstrom J., Lakka T.A., Eriksson J.G., Niskanen L., Wikstrom K., et al. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 2005, 54:158-165.
17. Li G., Zhang P., Wang J., Gregg E.W., Yang W., Gong Q., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008, 371:1783-1789.
18. Lindstrom J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemio K., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368:1673-1679.
19. Knowler W.C., Fowler S.E., Hamman R.F., Christophi C.A., Hoffman H.J., Brenneman A.T., et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374:1677-1686.
20. Rana J.S., Li T.Y., Manson J.E., Hu F.B. Adiposity compared with physical inactivity and risk of type 2 diabetes in women. Diabetes Care 2007, 30:53-58.
21. Hu F.B., Li T.Y., Colditz G.A., Willett W.C., Manson J.E. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003, 289:1785-1791.
22. Thomas D.E., Elliott E.J., Naughton G.A. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 2006, (3):CD002968.
23. 1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 2011, 305:1790-1799.
24. Wing R.R. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010, 170:1566-1575.
25. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
26. Verges B., Zeller M., Dentan G., Beer J.C., Laurent Y., Janin-Manificat L., et al. Impact of fasting glycemia on short-term prognosis after acute myocardial infarction. J Clin Endocrinol Metab 2007, 92:2136-2140.
27. Mittleman M.A., Maclure M., Tofler G.H., Sherwood J.B., Goldberg R.J., Muller J.E. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med 1993, 329:1677-1683.
28. Pavy B., Iliou M.C., Meurin P., Tabet J.Y., Corone S. Safety of exercise training for cardiac patients: results of the French registry of complications during cardiac rehabilitation. Arch Intern Med 2006, 166:2329-2334.
29. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
30. Myers J., Prakash M., Froelicher V., Do D., Partington S., Atwood J.E. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002, 346:793-801.
31. Cruickshanks KJ, Moss SE, Klein R, Klein BE. Physical activity and the risk of progression of retinopathy or the development of proliferative retinopathy. Ophthalmology 1995;102:1177-82$.
32. Cruickshanks K.J., Moss S.E., Klein R., Klein B.E. Physical activity and proliferative retinopathy in people diagnosed with diabetes before age 30 yr. Diabetes Care 1992, 15:1267-1272.
33. Lazarevic G., Antic S., Vlahovic P., Djordjevic V., Zvezdanovic L., Stefanovic V. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients. Ren Fail 2007, 29:199-205.
34. Tufescu A., Kanazawa M., Ishida A., Lu H., Sasaki Y., Ootaka T., et al. Combination of exercise and losartan enhances renoprotective and peripheral effects in spontaneously type 2 diabetes mellitus rats with nephropathy. J Hypertens 2008, 26:312-321.
35. Johansen K.L., Chertow G.M., Ng A.V., Mulligan K., Carey S., Schoenfeld P.Y., et al. Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int 2000, 57:2564-2570.
36. Balducci S., Iacobellis G., Parisi L., Di B.N., Calandriello E., Leonetti F., et al. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications 2006, 20:216-223.
37. Armstrong D.G., Lavery L.A., Holtz-Neiderer K., Mohler M.J., Wendel C.S., Nixon B.P., et al. Variability in activity may precede diabetic foot ulceration. Diabetes Care 2004, 27:1980-1984.
38. Kanade R.V., van Deursen R.W., Harding K., Price P. Walking performance in people with diabetic neuropathy: benefits and threats. Diabetologia 2006, 49:1747-1754.
39. Haskell W.L., Lee I.M., Pate R.R., Powell K.E., Blair S.N., Franklin B.A., et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007, 39:1423-1434.
40. Healy G.N., Matthews C.E., Dunstan D.W., Winkler E.A., Owen N. Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. Eur Heart J 2011, 32:590-597.
41. Colberg S.R., Sigal R.J., Fernhall B., Regensteiner J.G., Blissmer B.J., Rubin R.R., et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care 2010, 33:e147-e167.
42. Ciangura C., Oppert J.M. Éducation thérapeutique dans la prise en charge des maladies métaboliques: le rÔle de l'activité physique. Éducation thérapeutique: prévention et maladies chroniques 2009, 127-137. Masson ed., Paris. 2e édition. D. Simon, P.Y. Traynard, F. Bourdillon, R. Gagnayre, A. Grimaldi (Eds.).
43. Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J., et al. Compendium of physical activities: an update of activity codes and MET intensities 5. Med Sci Sports Exerc 2000, 32:S498-S504.
44. Bravata D.M., Smith-Spangler C., Sundaram V., Gienger A.L., Lin N., Lewis R., et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 2007, 298:2296-2304.
45. Charbonnel B., Bouhanick B., Le F.C. [Recommendations of SPC/ALFEDIAM on the care of diabetic patient as seen by the cardiologist]. Diabetes Metab 2004, 30:S2-S24.
46. Puel J., Valensi P. Recommandations conjointes SFC/ALFEDIAM. Identification de l'ischémie myocardique chez le diabétique. Arch Mal Coeur Vaiss 2004, 97:338-357.
47. DiClemente C.C., Prochaska J.O. Toward a comprehensive, transtheoretical model of change: stage of change and addictive behaviors. Treating addictive behaviors 1998, 3-24. Plenum, New York. 2nd edition. W.R. Miller, N. Heather (Eds.).
48. Duclos M., Coudeyre E., Ouchchane L. General practitioners' barriers to physical activity negatively influence type 2 diabetic patients' involvement in regular physical activity. Diabetes Care 2011, 34:e122.
49. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl. 2):S1-S113.
50. Duclos M., Duche P., Guezennec C.Y., Richard R., Riviere D., Vidalin H. Position de consensus: activité physique et obésité chez l'enfant et chez l'adulte. Sci Sports 2010, 25:207-225.
51. Poirier P., Tremblay A., Catellier C., Tancrede G., Garneau C., Nadeau A. Impact of time interval from the last meal on glucose response to exercise in subjects with type 2 diabetes. J Clin Endocrinol Metab 2000, 85:2860-2864.
52. Poirier P., Mawhinney S., Grondin L., Tremblay L., Broderick T., Cleroux J., et al. Prior meal enhances the plasma glucose lowering effect of exercise in type 2 diabetes. Med Sci Sports Exerc 2001, 33:1259-1264.